[Long-term results of iridocyclectomy for iris tumours]. 2008

D Daubner, and V Prokosch, and H Busse, and T Stupp
Universitätsaugenklinik, Universität Münster.

BACKGROUND The aim of this study was to evaluate the long-term survival rate and functional results after iridocyclectomy. METHODS Between 1980 and 2002 39 patients (26 female and 13 male) ranging in age from 20 to 79 years (median m = 58 years) underwent iridocyclectomy for a tumour of periphery iris by means of a lamellar technique or by trepanating. Follow-up time ranged from 3 months to 24 years (m = 11.2 years). RESULTS In 21 cases (54 %) there was a malignant tumour including 20 melanomas (mostly spindle-cell and mixed-cell melanomas) and one filiae of a bronchial carcinoma. There was a variety of histopathological entities in the 18 benign lesions (46 %). Naevi were the most frequent. The outcome was satisfactory: 57 % of the patients kept a visual acuity of > 0.5. Three eyes had to be enucleated. The rate of recurrence was 10 % (4 cases). The Kaplan-Meyer estimate for the 10-year-survival of the patients with a malignant iris tumour was 77 %. Two patients died of metastic melanoma following spindle-cell and mixed-cell melanoma. CONCLUSIONS The long-term functional results after Iridocyclectomy are good, whereas complications and recurrences are rare. The 10-year-survival is high. Over a long period iridocyclectomy is a recommendable surgical procedure for removal of progredient tumours of the anterior uvea.

UI MeSH Term Description Entries
D008137 Longitudinal Studies Studies in which variables relating to an individual or group of individuals are assessed over a period of time. Bogalusa Heart Study,California Teachers Study,Framingham Heart Study,Jackson Heart Study,Longitudinal Survey,Tuskegee Syphilis Study,Bogalusa Heart Studies,California Teachers Studies,Framingham Heart Studies,Heart Studies, Bogalusa,Heart Studies, Framingham,Heart Studies, Jackson,Heart Study, Bogalusa,Heart Study, Framingham,Heart Study, Jackson,Jackson Heart Studies,Longitudinal Study,Longitudinal Surveys,Studies, Bogalusa Heart,Studies, California Teachers,Studies, Jackson Heart,Studies, Longitudinal,Study, Bogalusa Heart,Study, California Teachers,Study, Longitudinal,Survey, Longitudinal,Surveys, Longitudinal,Syphilis Studies, Tuskegee,Syphilis Study, Tuskegee,Teachers Studies, California,Teachers Study, California,Tuskegee Syphilis Studies
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D015811 Iris Neoplasms Tumors of the iris characterized by increased pigmentation of melanocytes. Iris nevi are composed of proliferated melanocytes and are associated with neurofibromatosis and malignant melanoma of the choroid and ciliary body. Malignant melanoma of the iris often originates from preexisting nevi. Neoplasms, Iris,Iris Neoplasm,Neoplasm, Iris
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences
D015996 Survival Rate The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods. Cumulative Survival Rate,Mean Survival Time,Cumulative Survival Rates,Mean Survival Times,Rate, Cumulative Survival,Rate, Survival,Rates, Cumulative Survival,Rates, Survival,Survival Rate, Cumulative,Survival Rates,Survival Rates, Cumulative,Survival Time, Mean,Survival Times, Mean,Time, Mean Survival,Times, Mean Survival

Related Publications

D Daubner, and V Prokosch, and H Busse, and T Stupp
December 2001, Eye (London, England),
D Daubner, and V Prokosch, and H Busse, and T Stupp
November 1965, American journal of ophthalmology,
D Daubner, and V Prokosch, and H Busse, and T Stupp
January 1964, Transactions of the Pacific Coast Oto-Ophthalmological Society annual meeting,
D Daubner, and V Prokosch, and H Busse, and T Stupp
March 2017, American journal of ophthalmology,
D Daubner, and V Prokosch, and H Busse, and T Stupp
April 1990, Ophthalmology,
D Daubner, and V Prokosch, and H Busse, and T Stupp
December 1988, Klinische Monatsblatter fur Augenheilkunde,
D Daubner, and V Prokosch, and H Busse, and T Stupp
April 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery,
D Daubner, and V Prokosch, and H Busse, and T Stupp
November 2017, Journal of thoracic disease,
D Daubner, and V Prokosch, and H Busse, and T Stupp
June 1979, Ophthalmology,
D Daubner, and V Prokosch, and H Busse, and T Stupp
February 1986, Klinische Monatsblatter fur Augenheilkunde,
Copied contents to your clipboard!